Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study
- 31 January 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (1), 169-175
- https://doi.org/10.1016/s0301-472x(98)00067-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patientsBone Marrow Transplantation, 1997
- Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.Journal of Clinical Oncology, 1996
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cellsBlood, 1994
- Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]Blood, 1994
- Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.Journal of Clinical Oncology, 1994
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cellsBlood, 1989
- Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysisLeukemia Research, 1987
- Pharmacological purging of bone marrow with reference to autograftingClinics in Haematology, 1986